[Robotic-assisted operations for pathology of the aortoiliac segment: own experience]

Sh B Saaia1, A A Rabtsun1, I V Popova1

  • 1Cardiosurgical Department of Vascular Pathology and Hybrid Technologies, National Medical Research Centre named after Academician E.N. Meshalkin under the RF Ministry of Public Health, Novosibirsk, Russia.

Insights

Robotic-assisted surgery for aortoiliac conditions demonstrated high success rates (95%) with minimal trauma and blood loss. This advanced technique offers precise control for complex vascular anastomoses, proving feasible for treating aortoiliac segment pathologies.

Area of Science:

  • Vascular Surgery
  • Minimally Invasive Surgery
  • Robotic Surgery

Background:

  • Robotic-assisted surgery is increasingly explored for complex vascular procedures.
  • The da Vinci surgical system offers enhanced dexterity and visualization for intricate operations.

Purpose of the Study:

  • To assess the outcomes of robotic-assisted vascular operations on the aortoiliac segment.
  • To evaluate the feasibility and safety of the da Vinci system in treating aortic and iliac artery diseases.

Main Methods:

  • A total of 40 robotic-assisted vascular operations were performed between January 2013 and September 2019.
  • Procedures included 31 aortoiliac occlusions (aortofemoral bypass) and 9 infrarenal abdominal aortic aneurysm repairs.
  • Patients were divided into two groups based on the specific procedure performed.

Main Results:

  • Successful robotic-assisted surgery was achieved in 95% of cases, with only 5% requiring conversion to laparotomy.
  • Mean anastomosis time was 51 minutes; average blood loss was 316 ml.
  • The 30-day follow-up showed no lethal outcomes, thromboses, or prosthesis infections, with a 10% rate of non-lethal complications treated conservatively.

Conclusions:

  • Robotic-assisted surgery provides minimal trauma, reduced blood loss, and precise control for vascular anastomoses in challenging spaces.
  • The da Vinci system is a feasible and effective option for treating pathologies of the aortoiliac segment.
Abstract